MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$5,484K
Free Cash flow
-$34,845K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Maturities of available-for-sale...
Share-based compensation
Accrued personnel expenses
Others
Negative Cash Flow Breakdown
Purchases of available-for-sale ...
Net loss
Additions to property and equipm...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Loss on disposal of property and equipment
-
-
0
-
Net loss
-26,786
-26,189
-37,490
-25,969
Net accretion of discounts on available-for-sale securities
-661
-490
-400
-558
Foreign currency adjustments
-
-
-250
-
Loss on divestiture
-
-
0
-
Depreciation and amortization expense
1,141
1,126
1,011
775
Goodwill impairment
-
-
0
-
Accrued interest on held-to-maturity investments
-
-
-
0
In-process research and development impairment
-
-
10,000
-
Share-based compensation
3,046
2,553
2,309
2,156
Deferred income tax benefit
-
-
-793
-
Other noncash income, net
-36
-78
231
-14
Accounts receivable, net
211
52
-173
-46
Inventory related to discontinued operations (note 4)
-
-
0
-
Interest receivable
-142
392
-163
19
Inventory
-
-
-
0
Prepaid expenses and other current assets
155
327
-375
10
Accounts payable and accrued expenses
632
-4,213
-846
5,541
Deferred income
0
0
0
0
Accrued personnel expenses
2,096
-3,613
778
1,674
Other noncurrent liabilities
70
51
44
58
Net cash used in operating activities
-20,650
-31,468
-24,657
-16,292
Additions to property and equipment
14,195
6,858
5,075
1,992
Proceeds from the sale of property and equipment
-
-
0
-
Additions to other assets
21
0
51
39
Proceeds from maturity of held-to-maturity investments
-
-
0
-
Purchases of held-to-maturity investments
-
-
0
0
Proceeds from held-to-maturity securities
-
-
-
0
Purchases of available-for-sale securities
35,616
150,336
20,613
32,131
Maturities of available-for-sale securities
64,851
47,641
54,276
48,154
Net cash used in investing activities
15,019
-109,553
28,537
13,992
Repayment of note payable
13
15
13
13
Proceeds from sales of common stock, pursuant to exercise of warrants, net
-
-
0
0
Proceeds from sales of common stock, pursuant to exercise of options
160
290
0
226
Proceeds from the issuance of common stock and pre-funded warrants, net
-
-
-
0
Proceeds from the sales of common stock and pre-funded warrants, net
-
-
0
-
Proceeds from sale of common stock pursuant to at-the-market offering, net
-9,986
-
-
0
Proceeds from the issuance of common stock pursuant to the atm, net
-
-
9,986
-
Proceeds from issuance of common stock and pre-funded warrants, net
0
164,089
-
-
Net cash provided by financing activities
147
164,364
-13
213
Net increase (decrease) in cash and cash equivalents
-5,484
23,343
3,867
-2,087
Cash and cash equivalents at beginning of period
53,972
30,629
26,762
61,580
Cash and cash equivalents at end of period
48,488
53,972
30,629
26,762
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Maturities of
available-for-sale securities
$64,851K
(-9.32%↓ Y/Y)
something is missing
$9,986K
Proceeds from sales of
common stock, pursuant...
$160K
(10.34%↑ Y/Y)
Net cash used in
investing activities
$15,019K
(1254.42%↑ Y/Y)
Net cash provided by
financing activities
$147K
(-98.55%↓ Y/Y)
Canceled cashflow
$49,832K
Canceled cashflow
$9,999K
Net increase
(decrease) in cash and cash...
-$5,484K
(83.25%↑ Y/Y)
Canceled cashflow
$15,166K
Share-based compensation
$3,046K
(-32.33%↓ Y/Y)
Accrued personnel
expenses
$2,096K
(575.28%↑ Y/Y)
Depreciation and
amortization expense
$1,141K
(-22.12%↓ Y/Y)
Accounts payable and
accrued expenses
$632K
(113.90%↑ Y/Y)
Interest receivable
-$142K
(-149.65%↓ Y/Y)
Other noncurrent
liabilities
$70K
(-69.43%↓ Y/Y)
Other noncash income,
net
-$36K
(83.78%↑ Y/Y)
Purchases of
available-for-sale securities
$35,616K
(-46.92%↓ Y/Y)
Additions to property and
equipment
$14,195K
(149.82%↑ Y/Y)
Additions to other assets
$21K
(-53.33%↓ Y/Y)
Proceeds from sale of
common stock pursuant...
-$9,986K
(-200.00%↓ Y/Y)
Repayment of note payable
$13K
(-50.00%↓ Y/Y)
Net cash used in
operating activities
-$20,650K
(50.28%↑ Y/Y)
Canceled cashflow
$7,163K
Net loss
-$26,786K
(32.46%↑ Y/Y)
Net accretion of
discounts on...
-$661K
(62.55%↑ Y/Y)
Accounts receivable, net
$211K
(93.58%↑ Y/Y)
Prepaid expenses and
other current assets
$155K
(159.85%↑ Y/Y)
Buy us a coffee
Perspective Therapeutics, Inc. (CATX)
Perspective Therapeutics, Inc. (CATX)